Questionnaire

1. Compared to the control arm of THRIVE trial investigating the effects of the DASH diet plus advice, the average BP reduction of patients receiving this therapy was:

2. Weekly home-delivery of DASH groceries has been demonstrated to reduce systolic BP by:

3. There is a greater reduction in BP when tonlamarsen is given daily than when dosed monthly.

4. In the Ez-PAVE trial of statins plus ezetimibe, the intensively treated group achieved an LDL-C of:

5. In the VESALIUS-CVT study, evolocumab reduced the composite of coronary heart disease, death, MI and stroke by: 

6. Treatment with olezarsen reduced triglyceride concentrations by:

7. In the TARTAN-HF study, what percentage of asymptomatic diabetes patients were found to have HF as determined by NT-proBNF screening?

8. Significant reductions in emergency room visits and hospitalisations have been demonstrated after 90 days of a traditional diet in a Navajo population with HF.

9. Compared to oral anticoagulation only in participants of the HI-PEITHO trial with acute, intermediate-risk pulmonary embolism, using endovascular thrombolysis plus anticoagulation reduced recurrence by:

10. In the ORBITA-CTO trial of single-vessel total occlusion revascularisation in symptomatic patients, this procedure did not reduce the symptoms of angina.

11. The 10-year results of the HOST-EXAM trial of clopidogrel monotherapy compared to aspirin monotherapy after 1 year post-stent showed that clopidogrel reduced the risk for stroke by:

12. What percentage of MOMENTUM participants with resistant hypertension showed hypercortisolism after screening with a dexamethasone suppression test?

13. In a pooled analysis of patients treated with enlicitide, an oral PCSK9 inhibitor, LDL-C was reduced by:

14. Withdrawal of a beta-blocker after 1-year post-MI as compared to continuation of therapy resulted in:

15. Mavacamten, a selective cardiac myosin inhibitor used for the treatment of obstructive hypertrophic cardiomyopathy, is markedly successful: